Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 10/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.35 |
| ▸ | THRA | P10827 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23887694 | 1.00 | PPARD (0.37) | PPARDFFAR1KDM4EPKMHTT | |
| SCHEMBL23887878 | 0.88 | PTGDR2 (0.43) | PPARDFFAR1KDM4EPKMTHRB | |
| SCHEMBL23887753 | 0.86 | FFAR1 (0.36) | PPARDFFAR1PTGER2GRIN2BTHRA | |
| SCHEMBL23896086 | 0.86 | FFAR1 (0.38) | PPARDFFAR1PTGER2GRIN2B | |
| SCHEMBL25544111 | 0.85 | PTGDR2 (0.38) | PPARDFFAR1PTGER2THRATHRB | |
| SCHEMBL30121113 | 0.84 | TRPV3 (0.35) | PPARDFFAR1PTGER2GRIN2B | |
| SCHEMBL23895984 | 0.84 | TRPV3 (0.35) | PPARDFFAR1PTGER2GRIN2B | |
| SCHEMBL23887731 | 0.84 | FFAR1 (0.35) | PPARDFFAR1PTGER2GRIN2B | |
| SCHEMBL23888027 | 0.82 | GRIN2B (0.36) | FFAR1GRIN2B | |
| SCHEMBL30121100 | 0.82 | GRIN2B (0.36) | FFAR1GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126819-A1 | 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) | Vertex Pharmaceuticals Incorporated (US) | 2023-02-08 | — | — | EP | disclosed |